PepGen (PEPG) Earnings Date & Reports

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PEPG is expected to report earnings to rise 2.19% to -26 cents per share on November 11

Q3'26

Est.

$-0.27

Q2'26

Beat

by $0.03

Q1'26

Beat

by $0.03

Q4'25

Beat

by $0.10

Q3'25

Beat

by $0.04

The last earnings report on August 06 showed earnings per share of -25 cents, beating the estimate of -28 cents. With 478.80K shares outstanding, the current market capitalization sits at 217.47M.

View a ticker or compare two or three

PEPG

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days